Skip to content
PICO Portalanswers from OpenAlex

Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells

PaperCitations, authors & open-access status

Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells is a paper indexed in PICO Portal from OpenAlex.

How many citations does Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells have?

PICO Portalcitation count

Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells has 245 citations in the OpenAlex counts PICO Portal stores.

When was Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells published?

PICO Portalyear

Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells has 2014 year in the PICO Portal index.

What is the open-access status of Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells?

PICO Portaloa status

Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells has bronze oa status in the PICO Portal index.

What is the DOI of Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells?

PICO Portaldoi

The DOI for Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells is on the source record.

What is the PMID of Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells?

PICO Portalpmid

The PMID for Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells is on the source record.

What is the OpenAlex record for Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells?

PICO Portalopenalex

The OpenAlex for Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial